Listed by the USPTO as HINES, JANA A
Tech Center 1600 • Art Units: 1645
This examiner grants 53% of resolved cases
HINES, JANA A has resolved 714 cases in tech center 1600 and art unit 1645. The allowance rate is 53.2%, while interview lift is 39.4%. The positive interview measure indicates that interviews may materially improve prosecution outcomes in this docket, particularly when the applicant can present a focused response to examiner concerns.
The median time to allowance is 1244 days, so applicants should account for extended prosecution when planning business and continuation decisions. The recurring companies are Ojai Energetics Pbc, The University of Chicago, and Sanofi S.A. The recurring firms are Casimir Jones, S.C., MCKEE, VOORHEES & SEASE, P.L.C., and ARENTFOX SCHIFF LLP. Those participants provide concrete reference points for prosecution practice.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18031257 | GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18572974 | IMPROVED BACILLUS PRODUCTION HOST | Final Rejection | BASF SE |
| 16157885 | METHODS AND SYSTEMS, FOR INTERFERING WITH VIABILITY OF BACTERIA AND RELATED ANTIMICROBIALS AND COMPOSITIONS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17279012 | HIGH SPECIFICITY AND SENSITIVITY IMMUNOSORBENT DIAGNOSTIC ASSAYS WITH SIMULTANEOUS RESOLUTION OF MULTIPLE ANTIBODY ISOTYPES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18459221 | METHODS OF TREATING NON-SMALL CELL LUNG CANCER USING MESENCHYMAL EPITHELIAL TRANSITION FACTOR (MET)-TARGETED AGENTS | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18259219 | MICROBIAL MICROCAPSULE AND METHOD FOR PRODUCING SAME | Final Rejection | KAO CORPORATION |
| 18640574 | Antigenic OspA Polypeptides | Non-Final OA | SANOFI |
| 18746742 | MENINGOCOCCAL B RECOMBINANT VACCINE | Non-Final OA | SANOFI PASTEUR INC. |
| 18248491 | PROBIOTIC DELIVERY SYSTEMS AND METHODS OF MAKING AND USING | Non-Final OA | University of Louisville Research Foundation, Inc. |
| 17122594 | TESTING FOR PARTICULATES | Final Rejection | HERO SCIENTIFIC LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.2% of resolved applications examined by Jana A Hines were allowed (714 resolved cases), compared with 49.5% across Art Unit 1645 over the last five years.
This examiner's interview lift is +39.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jana A Hines took 1,244 days on average from filing to allowance.
Jana A Hines examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
